Maureen O'Keeffe-Rosetti, MS

Articles by Maureen O'Keeffe-Rosetti, MS

Incremental Healthcare Costs for Persons With Treatment-resistant Depression in Managed Care Organizations

ByFrances L. Lynch, PhD, MSPH,John Dickerson, PhD, MS,Maureen O'Keeffe-Rosetti, MS,Sanchita Sengupta, PhD,Wing Chow, PharmD, MPH,Jacqueline Pesa, PhD, MPH, MSEd

January 3rd 2020

Medical Care Costs Among Patients With Established Cardiovascular Disease

ByGregory A. Nichols, PhD,Timothy J. Bell, MHA,Kathryn L. Pedula, MS,Maureen O'Keeffe-Rosetti, MS

March 1st 2010

The economic burden of providing care to patients with cardiovascular disease, driven by secondary hospitalizations, may be substantially greater than current American Heart Association estimates.

Latest Updated Articles

Incremental Healthcare Costs for Persons With Treatment-resistant Depression in Managed Care Organizations
January 3rd 2020
Medical Care Costs Among Patients With Established Cardiovascular Disease
March 1st 2010

Maureen O'Keeffe-Rosetti, MS

Articles by Maureen O'Keeffe-Rosetti, MS

Incremental Healthcare Costs for Persons With Treatment-resistant Depression in Managed Care Organizations

Medical Care Costs Among Patients With Established Cardiovascular Disease

Latest Updated Articles

Trending on AJMC

Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials

Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI

Tozorakimab Curbs Multiple COPD Inflammatory Pathways, ERS Data Show

Cleveland Panel Weighs New HFpEF Pathway, Access to Finerenone

FDA Approves First Disease-Modifying Treatment for AxD